[MOL] Re: [multiplome myeloma/SCLC Abstracts and more...

["Lillian" <firefly@islc.net>]

Delayed cell transplantation for management of stem cell for multiple myeloma....

 

GERTZ MA, Lacy MQ, Inwards DJ, et al.
Delayed stem cell transplantation for the management of relapsed or
refractory multiple myeloma.
Bone Marrow Transplant 2000;26:45-50.
> >
> > Abstract:
> http://www.amedeo.com/lit.cfm?uid=A10918404&aid=B120230&dopt=r&s=lym

 

 

Thalidomide therapy caused life-threatening toxic epidemal necrolysis...

 

> > RAJKUMAR SV, Gertz MA, Witzig TE.
> > Life-threatening toxic epidermal necrolysis with thalidomide therapy for
> myeloma.
> > N Engl J Med 2000;343:972-3.

 

Circulating CD44 and interellular adhesion in low grad non-Hodgkin and B-cell chronic lyphocytic...

> > BEKSAC M, Arat M, Akan H, Koc H, Ilhan O, Ozcan M.
> > Circulating CD44 and intercellular adhesion molecule-1 levels in low grade
> non-Hodgkin lymphoma and B-cell chronic lymphocytic
> > leukemia patients during interferon-alpha-2a treatment.
> > Cancer 2000;89:1474-1481.
> >
> > Abstract:
> http://www.amedeo.com/lit.cfm?uid=A11013360&aid=B120230&dopt=r&s=lym

 

Serum midlkine levels are increased in patients with various types of carconomas.

IKEMATSU S, Yano A, Aridome K, et al.
> Serum midkine levels are increased in patients with various types of
carcinomas.
> Br J Cancer 2000;83:701-6.
>
> Abstract:
http://www.amedeo.com/lit.cfm?uid=A10952771&aid=B120237&dopt=r&s=ln
NISHIZAKA S, Gomi S, Harada K, Oizumi K, Itoh K, Shichijo S.
> A new tumor-rejection antigen recognized by cytotoxic T lymphocytes
infiltrating into a lung adenocarcinoma.
> Cancer Res 2000;60:4830-7.
>
> Abstract:
http://www.amedeo.com/lit.cfm?uid=A10987294&aid=B120237&dopt=r&s=ln

 

A new tumor antigen recognized by cytotoxic Tllymphocytes / lung carconomia...

NISHIZAKA S, Gomi S, Harada K, Oizumi K, Itoh K, Shichijo S.
> A new tumor-rejection antigen recognized by cytotoxic T lymphocytes
infiltrating into a lung adenocarcinoma.
> Cancer Res 2000;60:4830-7.
>
> Abstract:
http://www.amedeo.com/lit.cfm?uid=A10987294&aid=B120237&dopt=r&s=ln

 

Small Cell Lung Cancer

>
OSTERLIND K.
> LDH or NSE or LDH and NSE as pretreatment prognostic factors in small cell
lung cancer?. A commentary.
> Lung Cancer 2000;30:51-53.
>
> GATZEMEIER U, von Pawel J, Gottfried M, et al.
> Phase III Comparative Study of High-Dose Cisplatin Versus a Combination of
Paclitaxel and Cisplatin in Patients With Advanced
> Non-Small-Cell Lung Cancer.
> J Clin Oncol 2000;18:3390-3399.
>
> Abstract:
http://www.amedeo.com/lit.cfm?uid=A11013280&aid=B120237&dopt=r&s=ln